Expression of Recombinant pET22b-LysK-Cysteine/Histidine-Dependent Amidohydrolase/Peptidase Bacteriophage Therapeutic Protein in Escherichia coli BL21 (DE3)

Osong Public Health and Research Perspectives

Volumn 6, Issue 4, 2015, Pages 256-260

  Kashani, Hamed Haddad ^a   Moniri, Rezvan ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bacteriophage; Escherichia coli BL21 (DE3); LysK protein; pET22b vector

Indexed keywords

AMIDASE; BACTERIAL PROTEIN; CYSTEINE; HISTIDINE; ISOPROPYL THIOGALACTOSIDE; LYSK PROTEIN; PEPTIDASE; RESTRICTION ENDONUCLEASE; RNA POLYMERASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; CONTROLLED STUDY; ELECTROPHORESIS; ENTEROBACTERIA PHAGE T7; ESCHERICHIA COLI; ESCHERICHIA COLI BL21; GENE SEQUENCE; HINDIII GENE; LYSK GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; NCOI GENE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STAPHYLOCOCCUS; WESTERN BLOTTING;

EID: 84942191955     PISSN: 22109099     EISSN: 22336052     Source Type: Journal    
DOI: 10.1016/j.phrp.2015.08.001     Document Type: Article

References (38)

1. Loessner M.J. Bacteriophage endolysins-current state of research and applications. Curr Opin Microbiol 2005, 8:480-487.
2. Fenton M., Ross R.P., McAuliffe O., et al. Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs 2010, 1:9-16.
3. Loeffler J.M., Nelson D., Fischetti V.A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 2001, 294:2170-2172.
4. Zimmer M., Vukov N., Scherer S., et al. The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl Environ Microbiol 2002, 68:5311-5317.
5. O'Flaherty S., Coffey A., Meaney W., et al. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 2005, 187:7161-7164.
6. Loessner M.J., Maier S.K., Daubek-Puza H., et al. Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J Bacteriol 1997, 179:2845-2851.
7. Cheng Q., Nelson D., Zhu Z., et al. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother 2005, 49:111-117.
8. Entenza J.M., Loeffler J.M., Grandgirard D., et al. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother 2005, 49:4789-4792.
9. Grandgirard D., Loeffler J.M., Fischetti V.A., et al. Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J Infect Dis 2008, 197:1519-1522.
10. Jado I., Lopez R., Garcia E., et al. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 2003, 52:967-973.
11. Loeffler J.M., Djurkovic S., Fischetti V.A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 2003, 71:6199-6204.
12. McCullers J.A., Karlstrom A., Iverson A.R., et al. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog 2007 Mar, 3(3):e28.
13. Nelson D., Loomis L., Fischetti V.A. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A 2001, 98:4107-4112.
14. Schuch R., Nelson D., Fischetti V.A. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 2002, 418:884-889.
15. Rashel M., Uchiyama J., Ujihara T., et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage ΦMR11. J Infect Dis 2007, 196:1237-1247.
16. Daniel A., Euler C., Collin M., et al. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010, 54:1603-1612.
17. Garcia P., Lopez R., Ronda C., et al. Mechanism of phage induced lysis in pneumococci. J Gen Microbiol 1983, 129:479-487.
18. Fischetti V.A. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol 2010, 300:357-362.
19. Donovan D.M., Lardeo M., Foster-Frey J. Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbial Lett 2006, 265:133-139.
20. Obeso J.M., Martinez B., Rodriguez A., et al. Lytic activity of the recombinant staphylococcal bacteriophage phiH5 endolysin active against Staphylococcus aureus in milk. Int J Food Microbiol 2008, 128:211-218.
21. Becker S.C., Foster-Frey J., Donovan D.M. The phage K enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbial Lett 2008, 287:185-191.
22. Manoharadas S., Witte A., Blasi U. Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus. J Biotechnol 2009, 139:118-123.
23. Sass P., Bierbaum G. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 2007, 73:347-352.
24. Navarre W.W., Ton-That H., Faull K.F., Schneewind O. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem 1999, 274:15847-15856.
25. Nelson D., Schuch R., Cahales P., et al. PlyC: a multimeric bacteriophage lysin. Proc Natl Acad Sci U S A 2006, 103:10765-10770.
26. Loessner M.J., Kramer K., Ebel F., et al. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high- affinity binding to bacterial cell wall carbohydrates. Mol Microbiol 2002, 44:335-349.
27. Hermoso J.A., Monterroso B., Albert A., et al. Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1. Structure 2003, 11:1239-1249.
28. Loessner M.J., Gaeng S., Wendlinger G., et al. The two-component lysis system of Staphylococcus aureus bacteriophage twort: a large TTG-start holin and an associated amidase endolysin. FEMS Microbiol Lett 1998, 162:265-274.
29. Cheng Q., Fischetti V.A. Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci. Appl Microbiol Biotechnol 2007, 74:1284-1291.
30. Horgan M., O'Flynn G., Garry J., et al. The phage lysin, LysK, can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol 2009 Feb, 75(3):872-874. 10.1128/AEM.01831-08.
31. Low L.Y., Yang C., Perego M., et al. Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem 2005, 280:35433-35439.
32. Briers Y., Schmelcher M., Loessnen M.J., et al. The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144. Biochem Biophys Res Commun 2009, 383:187-191.
33. Cheng X., Zhang X., Pflugrath J.W., et al. The structure of bacteriophage T7 lysozyme, a zinc amidase and an inhibitor of T7 RNA polymerase. Proc Natl Acad Sci U S A 1994, 91:4034-4038.
34. Yoon S.H., Kim S.K., Kim J.F. Secretory production of recombinant proteins in Escherichia coli. Recent Pat Biotechnol 2010, 4:23-29.
35. Berkmen M. Production of disulfide-bonded proteins in Escherichia coli. Protein Expres Purif 2012, 82:240-251.
36. Schmelcher M., Shabarova T., Eugster M.R., et al. Rapid multiplex detection and differentiation of Listeria cells by use of fluorescent phage endolysin cell wall binding domains. Appl Environ Microbiol 2010, 76:5745-5756.
37. Fischetti V.A. Bacteriophage lysins as effective anti-bacterials. Curr Opin Microbiol 2008, 11:393-400.
38. Garcia P., Garcia J.L., Garcia E., et al. Modular organization of the lytic enzymes of Streptococcus pneumonia and its bacteriophages. Gene 1990, 86:81-88.